Resumen
The topical anti-inflammatory activity of epidermal growth factor (EGF) was evaluated in inflammation models induced by 12-O-tetradecanoylphorbol-13-acetate, croton oil and arachidonic acid. When EGF (1.5, 3 or 6 μg/ear) was coapplied with each inflammatory agent, there was a dose-related decrease in inflammation as assessed by ear punch weights, myeloperoxidase activity as well as by histopathological studies. The precise anti-inflammatory action of EGF is yet unclear, but we believe that interference with arachidonic acid metabolism may play an important role.
| Idioma original | Inglés |
|---|---|
| Páginas (desde-hasta) | 79-84 |
| Número de páginas | 6 |
| Publicación | Skin Pharmacology and Applied Skin Physiology |
| Volumen | 12 |
| N.º | 1-2 |
| DOI | |
| Estado | Publicada - 1999 |
| Publicado de forma externa | Sí |